Seaport Therapeutics
Clinical trials sponsored by Seaport Therapeutics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New depression drug SPT-300 enters Mid-Stage trial Results expected Mar 2027 (estimated)
- New depression drug SPT-300 moves to safety testing in extension trial Results expected May 2027 (estimated)